Earkart Ltd

Earkart Limited (formerly Earkart Private Limited) has announced its 5th Annual General Meeting (AGM) will be held on Wednesday, July 15, 2026, at 03:00 P.M. IST. The meeting will be conducted through Video Conferencing (VC) or Other Audio-Visual Means (OAVM), in compliance with regulatory circulars. The Notice for the 5th AGM and the Annual Report for FY 2025-26, including financial statements for the year ended March 31, 2026, will be sent electronically to shareholders. These documents will also be available on the company's website and the BSE India website. A cut-off date of Wednesday, July 8, 2026, has been set to determine eligible shareholders for voting. The company will also offer remote e-voting facilities.

Earkart Ltd has announced the incorporation of its foreign subsidiary, Earkart Health Limited, in the United Kingdom on June 8, 2026. The subsidiary has an authorized and paid-up share capital of GBP 10,000. Earkart Ltd holds a 65% stake, representing 650 equity shares, acquired at face value. The subsidiary's objective is to provide healthcare services and sell healthcare products. As a newly incorporated entity, it has no prior turnover. The incorporation required only standard registration formalities in the UK. The company's investment in the subsidiary's paid-up capital was GBP 6,500 in cash.

Earkart Ltd has announced the incorporation of two wholly-owned subsidiaries, Earkart Pharmaceuticals Private Limited and Earkart Healthcare Services Private Limited. The decision was approved during a board meeting held on May 29, 2026. Each subsidiary will have a proposed authorized and paid-up share capital of ₹1,00,000. Earkart Pharmaceuticals will focus on manufacturing and distributing pharmaceuticals, while Earkart Healthcare Services will provide services in the healthcare sector. The incorporation is a related party transaction, with the parent company subscribing to 100% of the initial paid-up capital in cash at face value of ₹10 per share.

Earkart Ltd's statutory auditor, M/s Timsi & Associates, Chartered Accountants, has issued an audit report with an unmodified opinion on the audited financial results for the half year and year ended March 31, 2026. The report will be available on the company's website.

Earkart Ltd's Board of Directors approved the audited standalone financial results for the half year and financial year ended March 31, 2026. The board also approved the appointment of M/s Arvind Aggarwal & Associates as Internal Auditor and M/s Nikita Kothari & Associates as Secretarial Auditor for FY 2026-27. The audited financial results and Independent Auditor’s Report issued by M/s Timsi & Associates are available on the company's website.

Earkart Limited's Board of Directors approved the audited standalone financial results for the half year and financial year ended March 31, 2026. The board also approved the appointment of M/s Arvind Aggarwal & Associates as Internal Auditor and M/s Nikita Kothari & Associates as Secretarial Auditor for FY 2026-27. The audited financial results and Independent Auditor’s Report are available on the company's website.

Earkart Ltd has scheduled a Board of Directors meeting on May 29, 2026, to consider and approve the audited financial statements for the quarter and financial year ended March 31, 2026, along with the Auditor’s Report. The board will also fix the date for the 5th Annual General Meeting of the company. The trading window, which was previously closed on March 30, 2026, will remain closed until May 31, 2026, for insiders, but will be open for general investors.

Earkart Ltd has appointed M/s. Arvind Aggarwal & Associates as the Internal Auditor for the Financial Year 2025-26. The Audit Committee recommended this appointment, which was approved by the Board of Directors at their meeting held on Monday, 30 March 2026. M/s. Arvind Aggarwal & Associates is a firm of Chartered Accountants specializing in internal audit, tax consultancy, and other related services.

Earkart Ltd, formerly known as Earkart Private Limited, has announced the closure of its trading window for dealing in listed equity shares. The closure will be in effect from Wednesday, 01 April 2026 until 48 hours after the declaration of Audited Financial Results for the quarter and year ended on 31 March 2026. This decision is in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015. All designated persons, their immediate relatives, and insiders of the company are advised not to enter or deal in any transaction involving the sale or purchase of Listed Securities during this period.

Earkart Ltd. has announced a meeting of the Board of Directors on March 30, 2026, to discuss and approve a variation in the objects/terms of utilization of the Initial Public Offering (IPO) proceeds and an extension of the time limit for utilizing the IPO proceeds. The company will make the details available on its website https://www.earkart.in for information, record, and appropriate dissemination.